Loading provider…
Loading provider…
Pulmonary Disease Physician in New York, NY
NPI: 1053408153Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Ahg of New York Inc
accredo.com
HQ Phone
Get MD Ronald's Phone Numberphone_androidMobile
Get MD Ronald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
CA State Medical License
1973
NY State Medical License
1993 - 2026
FL State Medical License
2017 - 2022

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Pulmonary Disease
Mass General Brigham/Massachusetts General Hospital
Residency • Internal Medicine
1968 - 1970
UCSF School of Medicine
medschool.ucsf.edu
Residency • Internal Medicine
1973 - 1973
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 1968
Authors: Prasad Adusumilli, Howard Federoff, Yuman Fong, Satiro De Oliveira, Nabil Ahmed, William Wierda, Leslie Popplewell, Jhanelle Gray, Donald Kohn
Journal: Hum Gene Ther
Authors: Schoenberger, C I, Line, B R, Keogh, B A, Hunninghake, G W, Crystal, R G
Journal: Thorax
In Vivo Cardiac Cellular Reprogramming Efficacy Is Enhanced by Angiogenic Preconditioning of the Infarcted Myocardium With Vascular Endothelial Growth Factor
Authors: Megumi Mathison, Robert P. Gersch, Ahmed Nasser, Sarit Lilo, Mallory B. Korman, Mitchell S. Fourman, Neil R. Hackett, Kenneth R. Shroyer, Jianchang Yang, Yupo Ma, Ronald G. Crystal, Todd K. Rosengart
Publication Date: 2012-12
Lead Sponsor: Weill Medical College of Cornell University
Intervention / Treatment: BIOLOGICAL: AdNull, BIOLOGICAL: AdVEGF-All6A+
Lead Sponsor: Lexeo Therapeutics
Collaborators: Alzheimer's Drug Discovery Foundation, Weill Medical College of Cornell University
Intervention / Treatment: BIOLOGICAL: LX1001
Lead Sponsor: Adverum Biotechnologies, Inc.
Intervention / Treatment: GENETIC: ADVM-043